Business Description
![GT Biopharma Inc GT Biopharma Inc logo](https://static.gurufocus.com/logos/0C00000C2C.png?14)
GT Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US36254L1008
Compare
Compare
Traded in other countries / regions
GTBP.USAOXIA.GermanyGTBP.France0RU9.UK Description
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 326.9 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.01 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 68.3 | |||||
3-Year EPS without NRI Growth Rate | 60.5 | |||||
3-Year FCF Growth Rate | 49.2 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.88 | |||||
9-Day RSI | 42.1 | |||||
14-Day RSI | 43.8 | |||||
6-1 Month Momentum % | -52.86 | |||||
12-1 Month Momentum % | -59.78 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.15 | |||||
Quick Ratio | 2.15 | |||||
Cash Ratio | 2.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -99.5 | |||||
Shareholder Yield % | 1.73 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -101.2 | |||||
ROA % | -61.45 | |||||
ROIC % | -2814.29 | |||||
ROC (Joel Greenblatt) % | -11442.99 | |||||
ROCE % | -90.63 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.77 | |||||
Price-to-Tangible-Book | 0.77 | |||||
EV-to-EBIT | 0.35 | |||||
EV-to-EBITDA | 0.35 | |||||
EV-to-FCF | 0.34 | |||||
Price-to-Net-Current-Asset-Value | 0.77 | |||||
Price-to-Net-Cash | 0.78 | |||||
Earnings Yield (Greenblatt) % | 285.71 | |||||
FCF Yield % | -158.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GTBP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GT Biopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -6.924 | ||
Beta | 1.07 | ||
Volatility % | 74.26 | ||
14-Day RSI | 43.8 | ||
14-Day ATR ($) | 0.44042 | ||
20-Day SMA ($) | 3.2365 | ||
12-1 Month Momentum % | -59.78 | ||
52-Week Range ($) | 2.61 - 10.95 | ||
Shares Outstanding (Mil) | 2.16 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GT Biopharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
GT Biopharma Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
GT Biopharma Inc Frequently Asked Questions
What is GT Biopharma Inc(GTBP)'s stock price today?
The current price of GTBP is $2.95. The 52 week high of GTBP is $10.95 and 52 week low is $2.61.
When is next earnings date of GT Biopharma Inc(GTBP)?
The next earnings date of GT Biopharma Inc(GTBP) is 2024-08-07 Est..
Does GT Biopharma Inc(GTBP) pay dividends? If so, how much?
GT Biopharma Inc(GTBP) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |